SPY329.00+0.21 0.06%
DIA267.00+0.28 0.11%
IXIC10,913.54+10.74 0.10%

BMO Capital Maintains Outperform on Morphic Holding, Lowers Price Target to $30

BMO Capital maintains Morphic Holding (NASDAQ:MORF) with a Outperform and lowers the price target from $32 to $30.

Benzinga · -

BMO Capital maintains Morphic Holding (NASDAQ:MORF) with a Outperform and lowers the price target from $32 to $30.